Mannkind (MNKD) Other Working Capital Changes (2010 - 2026)
Mannkind (MNKD) reported Other Working Capital Changes of -$939000.0 for Q1 2026, up 78.9% year-over-year from -$524877.5 in Q1 2025, and up 60.86% quarter-over-quarter from -$2.4 million in Q4 2025.
Mannkind (MNKD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Other Working Capital Changes data on file, last reported at -$939000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$939000.0, up 78.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 0.72% YoY), and the FY2025 annual result was $113550.0, down 10.37% from the prior year.
- Other Working Capital Changes climbed to -$939000.0 in Q1 2026 per MNKD's latest filing, from -$2.4 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $33.7 million in Q3 2023 and troughed at -$36.1 million in Q4 2023.
- A 5-year average of -$231529.4 and a median of -$939000.0 in 2026 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 10020.72% in 2023 and fell as far as 858.13% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.9 million in 2022, then slumped by 831.31% to -$36.1 million in 2023, then jumped by 129.86% to $10.8 million in 2024, then slumped by 122.25% to -$2.4 million in 2025, then jumped by 60.86% to -$939000.0 in 2026.
- Business Quant data shows MNKD's Other Working Capital Changes at -$939000.0 in Q1 2026, -$2.4 million in Q4 2025, and -$3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -939,000.00 |
| Mar 31, 2026 | -939,000.00 |
| Dec 31, 2025 | -2.40 Mn |
| Dec 31, 2025 | -2.40 Mn |
| Sep 30, 2025 | -3.85 Mn |
| Sep 30, 2025 | -3.85 Mn |
| Jun 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | -4.45 Mn |
| Mar 31, 2025 | -4.45 Mn |
| Dec 31, 2024 | 10.78 Mn |
| Dec 31, 2024 | 10.78 Mn |
| Sep 30, 2024 | -9.42 Mn |
| Sep 30, 2024 | -9.42 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Dec 31, 2023 | -36.11 Mn |
| Dec 31, 2023 | -36.11 Mn |